Syndax Pharmaceuticals (SNDX) Other Working Capital Changes (2015 - 2026)

Syndax Pharmaceuticals' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$12.4 million for Q3 2021.

• On a quarterly basis, Other Working Capital Changes fell 3156.58% year-over-year to -$12.4 million in Q3 2021; TTM through Dec 2022 was -$12.8 million, a 2.89% increase from a year earlier, with the FY2021 full-year figure at -$13.1 million, down 765.72% from the prior year.
• Other Working Capital Changes retreated to -$12.4 million in Q3 2021 per SNDX's latest filing, from -$379000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $14.5 million in Q4 2025 and bottomed at -$7.8 million in Q1 2026.
• The 5-year median for Other Working Capital Changes is -$1.4 million (2024), against an average of $416133.3.
• Across the five-year window, Other Working Capital Changes changed 0.0% in 2019 and sank 3156.58% in 2021, its largest moves.
• Year by year, Other Working Capital Changes stood at $3.8 million in 2017, then tumbled by 109.96% to -$379000.0 in 2018, then changed by 0.0% to -$379000.0 in 2019, then changed by 0.0% to -$379000.0 in 2020, then sank by 3165.17% to -$12.4 million in 2021.
• Per Business Quant, the three latest SNDX Other Working Capital Changes figures stand at -$12.4 million (Q3 2021), -$379000.0 (Q2 2021), and -$379000.0 (Q1 2021).